Table 2:
Changes in laboratory parameters over time between groups
| Safety visit | P value | 30-day visit | P value | |||
|---|---|---|---|---|---|---|
| Placebo | FMT | Placebo | FMT | |||
| MELD score | 11.7±3.9 | 10.2±4.5 | 0.44 | 11.3±3.9 | 8.7±2.9 | 0.11 |
| AST | 41.0±21.4 | 49.4±11.1 | 0.29 | 43.4±26.0 | 50.2±16.3 | 0.50 |
| ALT | 30.9±12.4 | 39.0±13.2 | 0.18 | 35.1±14.6 | 40.4±13.6 | 0.42 |
| Alkaline Phosphatase | 133.7±57.3 | 145.8±67.0 | 0.67 | 132.2±57.6 | 132.9±59.7 | 0.98 |
| INR | 1.32±0.22 | 1.29±0.16 | 0.73 | 1.31±0.23 | 1.23±0.14 | 0.40 |
| Bilirubin | 1.57±0.72 | 1.49±0.74 | 0.81 | 1.62±0.92 | 1.29±0.59 | 0.336 |
| Serum albumin | 3.17±0.57 | 3.33±0.48 | 0.51 | 3.32±0.67 | 3.52±0.49 | 0.46 |
| WBC (103/ml) | 5.1±2.2 | 4.9±1.5 | 0.83 | 5.1±2.0 | 5.0±1.3 | 0.93 |
| Hemoglobin (g/dl) | 11.7±2.8 | 13.4±1.8 | 0.13 | 12.5±2.9 | 13.9±1.5 | 0.20 |
| Platelet count(103/ml) | 146.4±85.6 | 108.4±31.8 | 0.22 | 142.9±76.5 | 116.0±53.3 | 0.38 |
Safety visit is 1-2 weeks after the initial EGD and Colonoscopy; comparisons performed using unpaired t-tests